EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Danaher's enterprise value is $208,760 Mil.
Danaher's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was $6,746 Mil. Therefore, Danaher's EV-to-EBITDA for today is 30.95.
The historical rank and industry rank for Danaher's EV-to-EBITDA or its related term are showing as below:
DHR'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.96 Med: 20.7 Max: 32.63
Current: 30.95
During the past 13 years, the highest EV-to-EBITDA of Danaher was 32.63. The lowest was 7.96. And the median was 20.70.
DHR's EV-to-EBITDA is ranked worse than 78.07% of 114
companies
in the Medical Diagnostics & Research industry
Industry Median: 16.405
vs DHR: 30.95
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Danaher EV-to-EBITDA Historical Data
The historical data trend for Danaher's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Danaher's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Danaher's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Danaher's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Danaher's EV-to-EBITDA falls into.
Danaher EV-to-EBITDA Calculation
Danaher's EV-to-EBITDA for today is calculated as:
Danaher's current Enterprise Value is $208,760 Mil.
Danaher's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $6,746 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Danaher (NYSE:DHR) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Danaher's share price for today is $268.81.
Danaher's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.630.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
Thank you for viewing the detailed overview of Danaher's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divesititure of its environmental and applied solutions group, Veralto.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DHR has been successfully added to your 